Revenue for Fluarix by GSK is expected to have a CAGR of 2.12% through 2038. How does that impact the rNPV of the drug?
DECEMBER 29, 2022
Influenza vaccine stimulate the body's immune system to recognize the agent as foreign and destroy it. It also helps the body's immune system to 'remember' the agent, so that the immune system can easily recognize and destroy any of the microbes that it encounters again in the future. Fluarix is indicated for active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine.